References
- Alexander B., Pechet L., Kliman A. Proteolysis, fibrinolysis and coagulation. Significance in thrombolytic therapy. Circulation 1962; 26: 596
- Alkjaersig N., Fletcher A. P., Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolysis (“fibrinolytic”) states. II. The significance, mechanism and consequence of defective polymerization. J. clin. Invest. 1962; 41: 917
- Bang N. U., Fletcher A. P., Alkjaersig N., Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. III. Demonstration of abnormal clot structure by electron microscopy. Ibid. 1962; 41: 935
- Fletcher A. P., Alkjaersig N., Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. I. The significance of fibrinogen proteolysis and circulating fibrinogen break down products. Ibid. 1962; 41: 896
- Godal H. C., Helle I. In vitro studies on fibrinogenolysis induced by streptokinase. Scand. J. clin. Lab. Invest. 1963; 15: 303
- Jacobsson K. Studies on the determination of fibrinogen in human blood plasma. Ibid. 1955; 7
- Schneider C. L. Rapid estimation of plasma fibrinogen concentration and its use as a guide of intravascular defibrination. Amer. J. Ob-stet. Gynec. 1952; 64: 141